Advances in Epigenetic Editing for Addiction Treatment
Crispr and other technologies are allowing researchers to turn on and off genetic and cellular switches impacting addictive behavior.
The Anticipation Wrinkle
Today, dopamine seems to be universally regarded as “the reward.” But the dopamine/eating link is also a two-way street.
Why Isn’t Big Pharma Investing in GLP-1 Trials for Substance Use Disorders?
There’s a noticeable lack of pharmaceutical company trials of GLP-1 drugs as treatments for substance use disorders.
Does Ozempic Cause Weight Loss by Impacting the Brain or the Gut?
A study from The Netherlands examines the impacts of GLP-1 agonists on the central nervous system using fMRI.
Is Ozempic the Gateway Drug for CBT?
Two recent studies show nearly twice the weight loss for patients who undergo group CBT in addition to taking liraglutide, a GLP-1 agonist.
Social Media Addiction Cases Dismissed Against Meta, Snap, TikTok, and Google
A California state judge dismissed school district claims that tech companies be held liable for social media addiction.